Leukemia Research
Volume 27, Issue 9 , Pages 859-863, September 2003

Sustained complete remission of CLL associated with the use of a Chinese herbal extract: case report and mechanistic analysis

  • Traci E. Battle

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115, USA
    • Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  • ,
  • Hugo Castro-Malaspina

      Affiliations

    • Memorial Sloan-Kettering Cancer Center, New York, NY, USA
  • ,
  • John G. Gribben

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115, USA
    • Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  • ,
  • David A. Frank

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115, USA
    • Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-617-632-4714; fax: +1-617-632-6356.

Received 3 October 2002; accepted 20 December 2002.

Abstract 

We report the case of a man with chronic lymphocytic leukemia (CLL) who, in the absence of cytotoxic chemotherapy, began taking a Chinese herbal extract. Shortly thereafter, he experienced a steady decline of his lymphocytosis and adenopathy, and he remains in remission now over 10 years later. The herbal extract inhibited the survival of primary CLL cells under in vitro culture conditions. However, it did not inhibit the activation of Akt or MAP kinase, nor did it inhibit the serine phosphorylation of STAT1. Thus, through an as yet unknown mechanism, this extract appears to exert pro-apoptotic effects in CLL.

Abbreviations: ALC, absolute lymphocyte count, CLL, chronic lymphocytic leukemia, FBS, fetal bovine serum, STAT, signal transducer and activator of transcription, WBC, white blood cell

Keywords: Apoptosis, Signal transduction, Complementary therapy, Non-Hodgkin’s lymphoma, Kinase, Protein phosphorylation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(03)00009-2

doi:10.1016/S0145-2126(03)00009-2

Leukemia Research
Volume 27, Issue 9 , Pages 859-863, September 2003